Skip to main content Skip to footer

Drug Tariff update – Omeprazole oral suspension

This is an announcement on behalf of the Department of Health and Social Care

The Department of Health and Social Care and the National Assembly of Wales have retrospectively determined from September 2023: 

  • the addition of Omeprazole 1mg/ml oral suspension sugar free (75ml) to Category C based on Rosemont Pharmaceuticals Ltd
  • the deletion of Omeprazole 5mg/5ml oral suspension from Part VIIIB

Payment for September and October’s prescriptions will reflect the above retrospective determination and hence will not be as per the published Drug Tariff.